Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New England Journal of Medicine: Vytorin-Cancer Link ‘Uncertain’
WSJ Online
Tuesday, September 2, 2008 - 10:27am
tags:
Eli Lilly says olanzapine study shows treatment benefit for up to six months
Trading Markets
Tuesday, September 2, 2008 - 10:24am
tags:
Glaxo heart drug seen promising despite trial miss
Forbes
Tuesday, September 2, 2008 - 10:23am
tags:
Novo Nordisk says to boost U.S. marketing
Guardian, UK
Tuesday, September 2, 2008 - 10:18am
tags:
Three Biotech Stocks That Could Double
The Street.com
Tuesday, September 2, 2008 - 10:17am
tags:
GlaxoSmithKline scales back relationship with Adolor
Bizjournals.com
Tuesday, September 2, 2008 - 10:12am
tags:
Glaxo Drug Misses Main Study Goal, Still Has Promise
Bloomberg
Tuesday, September 2, 2008 - 10:11am
tags:
U.K.'s SkyePharma Drops Most in 16 Years on Share-Sale Plan
Bloomberg
Tuesday, September 2, 2008 - 10:10am
tags:
Sciele a Buy Since January
Zacks.com
Tuesday, September 2, 2008 - 10:09am
tags:
Questions Arise Again on Vytorin Cancer Risk
CNBC
Tuesday, September 2, 2008 - 9:02am
tags:
Novacea to merge; Transcept to hold 60% of new firm
Marketwatch
Tuesday, September 2, 2008 - 9:00am
tags:
Boehringer Ingelheim: Phase III Dabigatran Data 2Q Or 3Q 09
CNN Money
Tuesday, September 2, 2008 - 8:59am
tags:
Biotech Outlook: M&A to Continue
Zacks.com
Tuesday, September 2, 2008 - 8:54am
tags:
Mylan's Alphapharm wins patent litigation on generic Razadyne tablets
Pharmaceutical Business Review
Tuesday, September 2, 2008 - 8:50am
tags:
Study: Drug sales may not benefit from ads directed to patients
USA Today
Tuesday, September 2, 2008 - 8:50am
tags:
China's Hepatitis B Market to Double by 2012
Seeking Alpha
Monday, September 1, 2008 - 11:33am
tags:
Glaxo Loses Preemption Ruling In Paxil Suicide
Pharmalot
Monday, September 1, 2008 - 11:32am
tags:
Shionogi to Buy Sciele Pharma to Get U.S. Sales Staff
Bloomberg
Monday, September 1, 2008 - 11:29am
tags:
Is a Hurricane Lurking for Merck and Schering-Plough?
Seeking Alpha
Sunday, August 31, 2008 - 10:53am
tags:
Ranbaxy emerges as top pharma company (in India) in July
Smart Money, India
Sunday, August 31, 2008 - 10:30am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.